Myambutol: Targeted Tuberculosis Treatment for Effective Bacterial Control
| Product dosage: 400mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.72 | $43.20 (0%) | 🛒 Add to cart |
| 90 | $0.55 | $64.79 $49.22 (24%) | 🛒 Add to cart |
| 120 | $0.46 | $86.39 $55.25 (36%) | 🛒 Add to cart |
| 180 | $0.38 | $129.59 $68.31 (47%) | 🛒 Add to cart |
| 270 | $0.32 | $194.38 $86.39 (56%) | 🛒 Add to cart |
| 360 | $0.29
Best per pill | $259.17 $104.47 (60%) | 🛒 Add to cart |
| Product dosage: 600mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.94 | $56.25 (0%) | 🛒 Add to cart |
| 90 | $0.77 | $84.38 $69.31 (18%) | 🛒 Add to cart |
| 120 | $0.69 | $112.51 $82.37 (27%) | 🛒 Add to cart |
| 180 | $0.61 | $168.76 $109.49 (35%) | 🛒 Add to cart |
| 270 | $0.55 | $253.14 $147.67 (42%) | 🛒 Add to cart |
| 360 | $0.53
Best per pill | $337.53 $189.86 (44%) | 🛒 Add to cart |
| Product dosage: 800mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.90 | $54.25 (0%) | 🛒 Add to cart |
| 90 | $0.81 | $81.37 $73.33 (10%) | 🛒 Add to cart |
| 120 | $0.78 | $108.49 $93.42 (14%) | 🛒 Add to cart |
| 180 | $0.74 | $162.74 $132.60 (19%) | 🛒 Add to cart |
| 270 | $0.71 | $244.10 $190.86 (22%) | 🛒 Add to cart |
| 360 | $0.69
Best per pill | $325.47 $247.12 (24%) | 🛒 Add to cart |
Synonyms | |||
Myambutol (ethambutol hydrochloride) is a first-line antimycobacterial agent specifically indicated for the treatment of pulmonary tuberculosis. It is used in combination with other antitubercular drugs to inhibit the growth of Mycobacterium tuberculosis, the causative pathogen of TB. This bacteriostatic medication works by suppressing arabinosyl transferase, an enzyme critical for mycobacterial cell wall synthesis. Administered orally, it is an essential component of standardized short-course chemotherapy regimens recommended by global health authorities, including the WHO and CDC, for both drug-susceptible and certain multidrug-resistant cases. Proper adherence to prescribed dosing and monitoring protocols is crucial for therapeutic success and minimizing risks of resistance or adverse effects.
Features
- Active pharmaceutical ingredient: Ethambutol hydrochloride
- Available in film-coated tablet formulations (100 mg, 400 mg, and 800 mg strengths)
- Bacteriostatic mechanism of action against Mycobacterium tuberculosis
- High oral bioavailability with peak plasma concentrations within 2–4 hours
- Distributed widely in body tissues, including lungs, kidneys, and cerebrospinal fluid
- Primarily excreted unchanged via renal pathway
- Manufactured under strict GMP and quality control standards
- Requires prescription and professional medical supervision
Benefits
- Effectively inhibits replication of tubercle bacilli when used as part of combination therapy
- Helps prevent development of drug-resistant TB strains through targeted mechanism
- Supports shorter, more manageable treatment durations in conjunction with other antitubercular drugs
- Oral administration facilitates outpatient treatment and improves adherence
- Contributes to higher cure rates and reduced transmission in community settings
- Allows for flexible dosing based on patient weight and renal function
Common use
Myambutol is primarily used in the treatment of all forms of pulmonary tuberculosis. It is always administered in combination with other antitubercular medications such as isoniazid, rifampin, and pyrazinamide to form standard first-line regimens. The drug may also be used in certain cases of atypical mycobacterial infections, though this is off-label and requires specialist oversight. Treatment typically occurs in two phases: an intensive initial phase aimed at rapid bacillary killing, followed by a continuation phase to eliminate persistent organisms and prevent relapse. Duration of therapy generally ranges from 6 to 9 months for drug-susceptible TB, though longer courses may be necessary for extrapulmonary or drug-resistant cases.
Dosage and direction
Dosage must be individualized based on patient weight and renal function. For adults and adolescents, the recommended dosage is 15–25 mg/kg body weight once daily, not to exceed 2.5 grams per day. Many guidelines recommend a fixed dose of 15 mg/kg for the entire treatment duration, though some protocols use higher doses during the intensive phase. Tablets should be taken whole with water, preferably on an empty stomach to maximize absorption, though they may be taken with food if gastrointestinal upset occurs. Dosage adjustment is necessary in patients with impaired renal function—typically reducing frequency to 2–3 times weekly rather than reducing individual doses. Pediatric dosing follows similar weight-based calculations, with close monitoring for adherence and tolerance.
Precautions
Baseline ophthalmological examination is mandatory before initiating therapy and should be repeated monthly during treatment. Visual acuity and color discrimination tests are essential, as ethambutol can cause optic neuropathy. Renal function should be assessed before treatment and monitored periodically, with dosage adjustments for patients with creatinine clearance below 30 mL/min. Hepatic function tests are recommended as part of overall safety monitoring. Patients should be educated to report any visual changes, including blurred vision, scotomas, or altered color perception, immediately. Use with caution in patients with pre-existing eye disorders, diabetic retinopathy, or renal impairment. Alcohol consumption should be minimized due to potential additive hepatic effects when combined with other antitubercular drugs.
Contraindications
Myambutol is contraindicated in patients with known hypersensitivity to ethambutol or any component of the formulation. It should not be used in patients with optic neuritis, unless no alternative treatment exists and benefits outweigh risks. The drug is contraindicated in children under 13 years old who cannot reliably report visual symptoms or undergo regular ophthalmological testing. Use is also contraindicated in patients with significant renal impairment who cannot be adequately dose-adjusted or monitored. Pregnancy category C—use during pregnancy only if clearly needed and potential benefits justify potential risks to the fetus.
Possible side effect
The most significant adverse effect is optic neuropathy, which may present as decreased visual acuity, scotomas, color blindness, or visual field constriction. This is generally reversible upon discontinuation if detected early but may become permanent with continued exposure. Other common side effects include gastrointestinal disturbances (nausea, abdominal pain, vomiting), dizziness, headache, and fever. Less frequently, hyperuricemia, arthralgia, and peripheral neuropathy may occur. Rash and pruritus represent hypersensitivity reactions. Elevated liver enzymes may be observed, though clinically significant hepatitis is rare when used alone. Rare reports include thrombocytopenia, leukopenia, and pneumonitis.
Drug interaction
Myambutol has relatively few clinically significant drug interactions. Aluminum-containing antacids may decrease ethambutol absorption if taken simultaneously—dosing should be separated by at least 2 hours. Neurotoxic medications, including other antitubercular drugs (especially isoniazid), may potentiate neurological side effects. It may slightly increase uric acid levels, which may interact with uricosuric agents. When used with other hepatotoxic drugs, monitoring for additive liver injury is recommended. No significant interactions with cytochrome P450 enzymes have been documented.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose. In that case, the missed dose should be skipped, and the regular dosing schedule resumed. Doubling doses to make up for a missed dose is not recommended. Consistent adherence is critical to treatment success and preventing resistance—patients should be counseled on the importance of regular dosing and provided with strategies to improve adherence, such as pill organizers or reminder systems. Any pattern of missed doses should be discussed with the healthcare provider to address underlying issues.
Overdose
Acute overdose may exacerbate dose-related adverse effects, particularly ocular toxicity. Symptoms may include visual disturbances, gastrointestinal upset, dizziness, and mental confusion. There is no specific antidote for ethambutol overdose. Management is supportive and symptomatic, including gastric lavage if presentation is early after ingestion. Hemodialysis may enhance elimination in patients with normal renal function, though data is limited. Patients should be monitored for visual changes, and ophthalmological consultation should be obtained. Serum ethambutol levels are not routinely available to guide management.
Storage
Store at controlled room temperature (20–25°C or 68–77°F) in a dry place protected from light and moisture. Keep in the original container with the lid tightly closed. Do not transfer tablets to other containers unless they provide equivalent protection from moisture. Keep out of reach of children and pets. Do not use beyond the expiration date printed on the packaging. Proper disposal of unused medication is important to prevent accidental ingestion or environmental contamination—consult local regulations for medication disposal programs.
Disclaimer
This information is intended for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting, changing, or stopping any medication. The prescribing physician should be aware of the patient’s complete medical history, including all medications and supplements being taken. Dosage and treatment duration must be individualized based on specific clinical circumstances. Patients should report any adverse effects to their healthcare provider promptly.
Reviews
“After being diagnosed with pulmonary TB, my regimen included Myambutol alongside rifampin and isoniazid. While the treatment requires discipline, my sputum conversion occurred by the second month, and I completed therapy without recurrence. Regular eye checkups were essential but manageable.” — Michael T., completed treatment 2022
“As an infectious disease specialist, I’ve prescribed Myambutol for over 15 years. Its targeted mechanism and generally favorable tolerability profile make it invaluable in TB regimens. The key is diligent monitoring for ocular toxicity, which we’ve successfully managed through patient education and monthly screenings.” — Dr. Elena Rodriguez, MD
“The weight-based dosing makes it adaptable for various patient populations. I’ve used it successfully in both adolescents and elderly patients, with appropriate renal adjustments. It remains a cornerstone of our TB control program.” — Clinical Pharmacist, TB clinic